Butterfly sciences was founded in 2009 to develop gene therapies for HIV and aging. Since founding, the company has completed patents in antibody based diagnostics for flow cytometry and developed gene therapy candidates and strategies for treatment of HIV-AIDS.

Butterfly Sciences additionally provides consulting services for biotech investment evaluations, and also for patients wishing to optimize treatment in oncology and other immunologically related areas.